Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma

Background: Gemcitabine, alone or in combination with other agents, has become an important part of the standard of care for treatment of both resectable and unresectable/advanced pancreatic adenocarcinoma. Gemcitabine is generally considered to have a favorable toxicity profile, with myelosuppressi...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Eiichiro, Crees, Zachary D., Crites, Danielle, Wang-Gillam, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933482/
https://www.ncbi.nlm.nih.gov/pubmed/30631842
http://dx.doi.org/10.1089/pancan.2017.0012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933482/
https://www.ncbi.nlm.nih.gov/pubmed/30631842
http://dx.doi.org/10.1089/pancan.2017.0012

Ejemplares similares